BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pitoia F, Jerkovich F, Trimboli P, Smulever A. New approaches for patients with advanced radioiodine-refractory thyroid cancer. World J Clin Oncol 2022; 13(1): 9-27 [PMID: 35116229 DOI: 10.5306/wjco.v13.i1.9]
URL: https://www.wjgnet.com/1948-5182/full/v13/i1/9.htm
Number Citing Articles
1
Yujia Liu, Jiafeng Wang, Xiaoping Hu, Zongfu Pan, Tong Xu, Jiajie Xu, Liehao Jiang, Ping Huang, Yiwen Zhang, Minghua Ge. Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategyDrug Resistance Updates 2023; 68: 100939 doi: 10.1016/j.drup.2023.100939
2
Jihwan Yoo, Hee Jun Kim, Seok Mo Kim, Hun Ho Park. Prognostic factors to predict the efficacy of surgical interventions against brain metastasis secondary to thyroid cancerEuropean Thyroid Journal 2022; 11(5) doi: 10.1530/ETJ-22-0087
3
Francis Worden, Olivera Rajkovic-Hooley, Neil Reynolds, Gary Milligan, Jingchuan Zhang. Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United StatesEndocrine 2023;  doi: 10.1007/s12020-023-03638-7
4
Fabian Pitoia, Rafael Selbach Scheffel, Ines Califano, Alicia Gauna, Hernán Tala, Fernanda Vaisman, Alejandro Roman Gonzalez, Ana Oliveira Hoff, Ana Luiza Maia. Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspectiveReviews in Endocrine and Metabolic Disorders 2024; 25(1): 109 doi: 10.1007/s11154-023-09818-0
5
Daisy Carolina Buenaventura, Hernando Vargas-Sierra, Natalia Aristizabal-Henao, Jose Luis Torres-Grajales, Carolina Aguilar-Londono, Johnayro Gutierrez-Restrepo. Posterior Reversible Encephalopathy Syndrome as an Adverse Effect of Lenvatinib in a Patient with Papillary Thyroid Carcinoma: A Case ReportInternational Journal of Endocrinology and Metabolism 2023; 21(3) doi: 10.5812/ijem-136900
6
E. Abou Jokh Casas, A. Repetto, A. Rodriguez Gasén, J.L. Vercher Conejero, P. Bello Arques, T. Cambil Molina, J.A. Vallejo Casas. Update on iodine-refractory differentiated thyroid carcinomaRevista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2023; 42(5): 325 doi: 10.1016/j.remnie.2023.07.003
7
E. Abou Jokh Casas, A. Repetto, A. Rodríguez Gasén, J.L. Vercher Conejero, P. Bello Arques, T. Cambil Molina, J.A. Vallejo Casas. Actualización en carcinoma diferenciado de tiroides refractario a radioyodoRevista Española de Medicina Nuclear e Imagen Molecular 2023; 42(5): 324 doi: 10.1016/j.remn.2023.06.005
8
Giusy Elia, Armando Patrizio, Francesca Ragusa, Sabrina Rosaria Paparo, Valeria Mazzi, Eugenia Balestri, Chiara Botrini, Licia Rugani, Salvatore Benvenga, Gabriele Materazzi, Claudio Spinelli, Alessandro Antonelli, Poupak Fallahi, Silvia Martina Ferrari. Molecular features of aggressive thyroid cancerFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1099280